News | October 21, 2009

Raydiance Achieves Breakthrough for Manufacturing Bioabsorbable Stents

This bioabsorbable stent with 80 micron struts and 3.5 mm diameter was machined with Raydiance Smart Light, the world's only commercial grade ultrafast laser platform.


October 21, 2009 – Raydiance Corp., developer of the world’s first commercial-grade ultrafast laser, said today it made a major breakthrough in manufacturing a wide variety of bioabsorbable materials with precise, micron-resolution feature sizes and with no heat affected zones (HAZ).

Raydiance has been deploying its Smart Light MD platform with leading medical device companies to manufacture a range of bioabsorbable vascular stent designs and materials, as well as other biocompatible polymers.

The recent Raydiance work was performed on bioabsorbable materials such as polylactic acid, polyglycolic acid, and a variety of copolymers. The vascular stents machined by Raydiance had strut dimensions of 80 microns and less.

“The medical device industry has embarked on an exciting wave of innovation in small, extremely precise implantable devices,” said Scott Davison, president of Raydiance. “These new products and applications require a new tool that enables the machining of very small features without introducing heat to the process. Raydiance Smart Light is that tool.”

Raydiance will discuss this advance at the Medical Design and Manufacturing show in Minneapolis today and tomorrow.

For more information: www.raydiance-inc.com


Related Content

News | Stents

April 17, 2024 — Getinge and Cook Medical announced an exclusive sales and distribution agreement for the iCast covered ...

Home April 17, 2024
Home
News | Stents

March 8, 2024 — Silk Road Medical, Inc., a company focused on reducing the risk of stroke and its devastating impact ...

Home March 08, 2024
Home
News | Stents

January 19, 2024 — W. L. Gore & Associates, Inc. announced that the first patients have been enrolled in the Gore VBX ...

Home January 19, 2024
Home
News | Stents

November 29, 2023 — InspireMD, Inc., developer of the CGuard Embolic Prevention Stent System (EPS) for the prevention of ...

Home November 29, 2023
Home
News | Stents

July 27, 2023 — Abiomed is recalling the Impella Intravascular Left Sided Blood Pumps because the pump’s Instructions ...

Home July 27, 2023
Home
News | Stents

June 13, 2023 — W. L. Gore & Associates (Gore) announced the initiation of the Gore VBX FORWARD Clinical Study ...

Home June 13, 2023
Home
News | Stents

March 5, 2023 — In patients with multi-vessel heart disease who have had a heart attack, immediate treatment with stents ...

Home March 05, 2023
Home
News | Stents

January 23, 2023 — A study of more than 100,000 patients has revealed that, for patients with blockages in multiple ...

Home January 23, 2023
Home
News | Stents

July 5, 2022 — A BIO-RESORT subgroup analysis of outcomes in small coronary vessels (<2,5mm) evaluated the efficacy and ...

Home July 05, 2022
Home
News | Stents

June 2, 2022 — According to the U.S. Food and Drug Administration (FDA), Atrium Medical Corporation is recalling the ...

Home June 02, 2022
Home
Subscribe Now